In fact, GLP-1 use is about to get bigger
Diabetes Care (2010) 33:234954
Prasad, K.N., C, C., Karthik, Y., Girish, G.V
27 A total of 703 participants with uncontrolled T2DM (A1C of 7.09.5%) were randomized into four treatment groups that included a daily dose of either 3 mg, 7 mg, or 14 mg of oral semaglutide or placebo for 26 weeks
Heres a quick look at some top options: GLP-1 Agonists : Wegovy, Ozempic, Semaglutide Appetite Suppressants : Phentermine, Contrave, Qsymia Lipase Inhibitors : Orlistat (Xenical, Alli) Other Effective Medications : Plenity, Setmelanotide Finding the right weight loss medication is crucial for effective and sustainable weight management
Zepbound (tirzepatide) is fully approved by the FDA and widely available for both type 2 diabetes and weight loss